On the other hand, this also makes it difficult to test the in vivo efficacy of TF-targeted therapies as a result of only eradicating CSCs alone, due to the observations that TF is expressed additionally on cancer cells and/or tumor vasculature in vivo in animal tumor models [13, 15]. This evidence concerns the gene TF and neoplasm.